BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Dolphin Medical Services Ltd. Share Price

NSE
BSE

BSE : 526504

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

High

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 7.79 1.44
Expenses N/A N/A
PBT -0.31 -0.66
Operating profit 0.0 0.0
Net profit -0.34 -0.7

Shareholding Pattern

Promoters (% Holding)

26.44%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

73.56%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Dolphin Medical Services Ltd.

Founded 1992
Managing Director G V Mohan Prasad

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,29,468.96 1,787.20 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,73,304.53 6,499.35 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,46,013.82 4,285.05 3,102.00 - 3,102.00
Apollo Hospitals Enterprise Ltd. 1,16,410.22 8,107.00 6,696.50 - 6,696.50
Cipla Ltd. 1,11,387.62 1,378.90 1,165.70 - 1,165.70
Zydus Lifesciences Ltd. 1,08,396.56 1,080.20 835.50 - 835.50
Dr. Reddy's Laboratories Ltd. 1,06,381.20 1,276.40 1,148.40 - 1,148.40
Lupin Ltd. 1,02,852.99 2,252.90 1,836.80 - 1,836.80
Mankind Pharma Ltd. 94,907.18 2,300.45 1,909.70 - 1,909.70
Max Healthcare Institute Ltd. 92,414.36 949.55 903.00 - 903.00
no-content No Records Found

Latest News

May
16
2026
EQUITY Posted on May 16th 2026

Dolphin Medical Services submits intimation of open offer

Dolphin Medical Services has informed that, Rarever Financial Advisors (Manager to the Offer) has submitted the public announcement to the shareholders of Dolphin Medical Services (Target Company) in terms of Regulation 4 of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
2
2026
EQUITY Posted on Jun 2nd 2026

Hindustan Bio Sciences informs about newspaper publication

Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hindustan Bio Sciences has informed that the Audited financial results of the Company for the quarter and year ended March 31, 2026 were published by the company on 02-06-2026 in Hitech Edition (in English language) and 01-06-2026 in The Praja Palana (in Telugu language) newspapers. A copy of same is enclosed. This intimation shall also be available on the Company’s website at www.hindustanbiosciences.in.
The above information is a part of company’s filings submitted to BSE. 
Read More
Jun
2
2026
EQUITY Posted on Jun 2nd 2026

Gland Pharma informs about allotment of equity shares

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; Gland Pharma has informed that the ESOP Compensation Committee of the Board of Directors of the Company in its meeting held on June 02, 2026, has allotted 2,03,259 Equity shares of Re 1 each of the Company, fully paid up, to 77 employee(s) on exercise of their Stock Options pursuant to Gland Pharma Employee Stock Options Scheme, 2025. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs 164,959,682 comprising 164,959,682 Equity shares of face value Re 1 each. Further, it has enclosed the details as required under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

The above information is a part of company’s filings submitted to BSE. 

Read More
Jun
2
2026
EQUITY Posted on Jun 2nd 2026

Shelter Pharma informs about receipt of renewal manufacturing licence

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shelter Pharma has informed that Shelter Pharma has received the Renewal Manufacturing Licence (Form 25D) from the Food & Drugs Control Administration (Ayurved), Government of Gujarat, for manufacturing Ayurvedic products at its manufacturing facility situated at, Near S.T Bus Stand, Himatnagar - 383001 Gujrat. The renewed licence has been granted by the competent authority and is valid up to September 2030, subject to compliance with applicable regulatory requirements. The renewal enables the Company to continue its manufacturing operations without interruption and further strengthens its regulatory standing. The Management believes that the renewed licence reflects the Company's strong regulatory compliance framework and provides a solid foundation for sustained growth and value creation. The details as required under Regulation 30 of the SEBI (LODR) Regulations, 2015 are enclosed as Annexure - A.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
2
2026
EQUITY Posted on Jun 2nd 2026

Vivo Bio Tech informs about press release

Vivo Bio Tech has informed that it enclosed the copies of advertisement issued in newspapers on June 02, 2026, in ‘Financial Express’ in English Language and in ‘Nava Telangana’ in Telugu Language, with respect to the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Dolphin Medical Services Ltd. ?

The current share price of Dolphin Medical Services Ltd. is ₹7.52 as of 2026-06-01.

The market capitalisation of Dolphin Medical Services Ltd. is ₹11.36 as of 2026-06-01.

The 1-year return of Dolphin Medical Services Ltd. is 5.31% as of 2026-06-01.

The P/E ratio of Dolphin Medical Services Ltd. is 0.00 as of 2026-06-03.

The 52-week high and low of Dolphin Medical Services Ltd. are ₹7.52 and ₹1.98, respectively, as of 2026-06-01.

The dividend yield of Dolphin Medical Services Ltd. is 0.0% as of2026-06-01.

You can buy Dolphin Medical Services Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Dolphin Medical Services Ltd. is G V Mohan Prasad.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore